肿瘤管理进展:释放组织碎化技术的潜力
组织碎化技术是一种无创、非电离、非热消融技术,通过高强度聚焦超声产生空化气泡机械粉碎组织。临床前和临床研究显示其对肝、胰、肾和前列腺肿瘤有效,安全性总体良好,不良反应轻微,但需进一步研究优化技术并了解长期效应。
要点
- 组织碎化技术利用高强度聚焦超声产生空化气泡,机械粉碎组织为无细胞碎片。
- 临床前和临床研究显示对肝、胰、肾和前列腺肿瘤有疗效。
- 安全性总体良好,报告的不良反应轻微。
核心结论
- 组织碎化技术是一种有潜力替代手术治疗的无创、非电离、非热消融技术,对多种肿瘤有效且安全性良好,但需进一步研究优化技术和了解长期效应。
研究设计与样本
- 综述,讨论组织碎化技术的原理、临床前和临床文献及其安全性,以及潜在临床应用;检索范围和纳入文献未报告。
临床应用与阅片要点
- 作者认为组织碎化技术有潜力在多种临床场景中替代手术干预。
- 作者指出需进一步研究优化技术并了解长期效应。
局限性
- 需进一步研究优化技术并了解长期效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Tissue ablation techniques have long been used in clinical settings to treat various oncologic diseases. However, many of these techniques are invasive and can cause substantial adverse effects. Histotripsy is a noninvasive, nonionizing, nonthermal tissue ablation technique that has the potential to replace surgical interventions in various clinical settings. Histotripsy works by delivering high-intensity focused ultrasound waves to target tissue. These waves create cavitation bubbles within tissues that rapidly expand and collapse, thereby mechanically fractionating the tissue into acellular debris that is subsequently absorbed by the body's immune system. Preclinical and clinical studies have demonstrated the efficacy of histotripsy in treating a range of diseases, including liver, pancreatic, renal, and prostate tumors. Safety outcomes of histotripsy have been generally favorable, with minimal adverse effects reported. However, further studies are needed to optimize the technique and understand its long-term effects. This review aims to discuss the importance of histotripsy as a noninvasive tissue ablation technique, the preclinical and clinical literature on histotripsy and its safety, and the potential applications of histotripsy in clinical practice. Keywords: Tumor Microenvironment, Ultrasound-High-Intensity Focused (HIFU), Ablation Techniques, Abdomen/GI, Genital/Reproductive, Nonthermal Tissue Ablation, Histotripsy, Clinical Trials, Preclinical Applications, Focused Ultrasound © RSNA, 2024.
引用
- Verma Y, Perera Molligoda Arachchige AS. Advances in Tumor Management: Harnessing the Potential of Histotripsy. Radiol Imaging Cancer. 2024. PMID: 38639585. doi:10.1148/rycan.230159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。